Ball & Co Wealth Management »

Allogene Therapeutics shares owned by Ball & Co Wealth Management

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Ball & Co Wealth Management from 13F filings

Historical chart of Ball & Co Wealth Management investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Ball & Co Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Ball & Co Wealth Management

Quarter filed Position value Share count Share price at filing
2025-06-30 $0 500 0.00
2025-03-31 $0 500 0.00
2024-12-31 $1.0k 500 2.00

More positions owned by Ball & Co Wealth Management

Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard Specialized Funds Div App Etf (VIG)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Eafe Value Etf (EFV)
Capital Group Dividend Value Shs Creation Uni (CGDV)
Select Sector Spdr Tr Sbi Healthcare (XLV)
Alps Etf Tr Alerian Mlp (AMLP)
Series Portfolios Tr Eldridge Bbb B (CLOZ)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Series Portfolios Tr Eldridge Aaa Clo (CLOX)
Amgen (AMGN)
Ishares Silver Tr Ishares (SLV)
Select Sector Spdr Tr Indl (XLI)
Ishares Tr Russell 2000 Etf (IWM)
Fidelity Covington Trust Enhanced Large (FELG)

View all positions for Ball & Co Wealth Management

Top funds holding Allogene Therapeutics

Pfizer
Tpg Gp A
BlackRock
Citadel Advisors
Vanguard Group
PRIMECAP Management Company
Woodline Partners
Frazier Life Sciences Management
Geode Capital Management
UBS Group
Millennium Management
Two Sigma Investments
Patient Square Capital
Wildcat Capital Management
Renaissance Technologies

View all funds holding Allogene Therapeutics